{
       "StudyFieldsResponse": {
              "APIVrs": "1.01.05",
              "DataVrs": "2022:12:27 23:33:24.623",
              "Expression": "spaceflight medicine",
              "NStudiesAvail": 437410,
              "NStudiesFound": 12,
              "MinRank": 1,
              "MaxRank": 1000,
              "NStudiesReturned": 12,
              "FieldList": [
                     "OverallOfficialName",
                     "OverallOfficialRole",
                     "OverallStatus",
                     "OversightHasDMC",
                     "PatientRegistry",
                     "Phase",
                     "PointOfContactEMail",
                     "PointOfContactOrganization",
                     "PointOfContactPhone",
                     "PointOfContactPhoneExt",
                     "PointOfContactTitle",
                     "PrimaryCompletionDate",
                     "PrimaryCompletionDateType",
                     "PrimaryOutcomeDescription",
                     "PrimaryOutcomeMeasure",
                     "NCTId"
              ],
              "StudyFields": [
                     {
                            "Rank": 1,
                            "OverallOfficialName": [
                                   "Smith Johnston, MD",
                                   "David Dinges, PhD"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator",
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [
                                   "No"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Phase 4"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "July 15, 2015"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "The number of lapses of attention on 3 minute Psychomotor Vigilance Test"
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Number of lapses of attention"
                            ],
                            "NCTId": [
                                   "NCT03526575"
                            ]
                     },
                     {
                            "Rank": 2,
                            "OverallOfficialName": [],
                            "OverallOfficialRole": [],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [
                                   "No"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Phase 1"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "July 2015"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "Transcranial Doppler derived measurements of mean cerebral blood flow velocity",
                                   "Cerebrotech monitor derived intracranial fluid volume changes (percentage change)",
                                   "Vittamed ICP meter derived intracranial pressure (mmHg)",
                                   "Cognition battery score (max 1000): tests multiple cognitive domains including spatial memory, psychomotor processing speed, facial emotional recognition",
                                   "cFLOW derived changes in cerebral blood flow index"
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Changes in cerebral blood flow: Transcranial doppler",
                                   "Changes in intracranial volume",
                                   "Changes in intracranial pressure",
                                   "Changes in cognitive function",
                                   "Changes in cerebral blood flow: cFLOW"
                            ],
                            "NCTId": [
                                   "NCT02493985"
                            ]
                     },
                     {
                            "Rank": 3,
                            "OverallOfficialName": [
                                   "Kathy Miller, MD"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [
                                   "Yes"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Not Applicable"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "March 29, 2018"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "Analysis of the modified intent-to-treat population defined as patients with at least 1 post-baseline measurement as well as eligible patients who decline participation, reason for refusal, and number of enrolled patients who do not complete all LOFT training sessions"
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Feasibility of LOFT therapy in breast cancer survivors (< 3 years from diagnosis) treated with either chemotherapy and/or anti-estrogen therapy"
                            ],
                            "NCTId": [
                                   "NCT02491957"
                            ]
                     },
                     {
                            "Rank": 4,
                            "OverallOfficialName": [],
                            "OverallOfficialRole": [],
                            "OverallStatus": [
                                   "Enrolling by invitation"
                            ],
                            "OversightHasDMC": [
                                   "No"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Not Applicable"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "December 31, 2033"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Anticipated"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "Cognitive efficiency across domains as determined with the Cognition test battery",
                                   "fMRI local task activation while performing the MRI version of Cognition in the scanner",
                                   "Accuracy and reaction times for each cognitive task as determined with the Spatial Cognition test batteries",
                                   "Structural brain changes assessed with MRI",
                                   "fMRI local task activation while performing visuospatial tasks in the scanner",
                                   "Changes in Brain-Derived Neurotropic Factor (BDNF)"
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Cognitive performance",
                                   "Local task activation Cognition",
                                   "Spatial cognition performance",
                                   "Structural brain changes",
                                   "Local task activation Spatial Cognition",
                                   "Brain-Derived Neurotropic Factor (BDNF)"
                            ],
                            "NCTId": [
                                   "NCT04856410"
                            ]
                     },
                     {
                            "Rank": 5,
                            "OverallOfficialName": [
                                   "Scott M Smith, PhD"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [
                                   "No"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Not Applicable"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "November 2015"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "24-h NTX will be used as an indicator of bone resorption"
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Change in urinary n-telopeptide after 15 days of space flight compared to preflight",
                                   "Change in urinary n-telopeptide after 30 days of space flight compared to preflight",
                                   "Change in urinary n-telopeptide after 60 days of space flight compared to preflight",
                                   "Change in urinary n-telopeptide after 120 days of space flight compared to preflight",
                                   "Change in urinary n-telopeptide after 180 days of space flight compared to preflight",
                                   "Change in urinary calcium after 15 days of space flight compared to preflight",
                                   "Change in urinary calcium after 60 days of space flight compared to preflight",
                                   "Change in urinary calcium after 120 days of space flight compared to preflight",
                                   "Change in urinary calcium after 180 days of space flight compared to preflight"
                            ],
                            "NCTId": [
                                   "NCT01713634"
                            ]
                     },
                     {
                            "Rank": 6,
                            "OverallOfficialName": [
                                   "Jacques Bernard, Dr"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Phase 1"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [],
                            "PrimaryCompletionDateType": [],
                            "PrimaryOutcomeDescription": [],
                            "PrimaryOutcomeMeasure": [
                                   "Muscle size and function",
                                   "Muscle protein composition, muscle fiber type composition andmuscle enzyme content of soleus and vastus lateralis muscles",
                                   "Bone mineral content and structure",
                                   "Isokinetic muscle strength (using Cybex)",
                                   "Fluid volume shift",
                                   "Calcium metabolism and hormonal control",
                                   "Sleep assessment by questionnaires and actigraphy",
                                   "RR interval from an ECG lead signal by an high impedance probe, Systolic (SAP), Diastolic (DAP) and Mean arterial pressure (MAP) by Finapres (or Portapres) andRespiration by a piezoelectric pneumobelt,",
                                   "Acetaminophen pharmacokinetic parameters,",
                                   "24 h profile of spine geometry,flexibility index of spine, activity of lower back muscles,",
                                   "and subjective rating of back pain",
                                   "Maximal oxygen consumption.",
                                   "Cardiovascular oxygen transport (oxygen delivery and oxygen return), requiring measurement of cardiac output, heart rate, arterialized blood gas composition, and arterial oxygen saturation.",
                                   "Gas exchange kinetics at the onset and offset of exercise, requiring measurement of breath-by-breath ventilation and expired gas composition.",
                                   "Blood volume",
                                   "Plasma concentrations of arginin vasopressin, atrial natriuretic peptide, renin, endothelin, cyclic GMP and catecholamines. Urine concentrations of catecholamines, arginin vasopressin and cyclic GMP Blood concentration of nitric oxide.",
                                   "Total energy expenditure, Lipid metabolism, body composition, water turnover and the formation of metabolic water.",
                                   "Heart rate variability and post-ganglionic sympathetic nerve activity.",
                                   "Arterial cardiac chronotropic baroreflex sensitivity and ventricular interdependence.",
                                   "Ventricular mass and cardiac dimension.",
                                   "Muscle architecture, including angle of pennation, fibre length, muscle thickness and muscle cross-sectional area",
                                   "Energetics and biomechanics of walking and running",
                                   "Parameters of vascular peripheral hemodynamics",
                                   "Parameters of central hemodynamics"
                            ],
                            "NCTId": [
                                   "NCT00311571"
                            ]
                     },
                     {
                            "Rank": 7,
                            "OverallOfficialName": [
                                   "Benjamin Levine, MD"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [
                                   "No"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Not Applicable"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "March 1, 2020"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "The change in choroid area measured by optical coherence tomography.",
                                   "The change in choroid volume measured by optical coherence tomography."
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Change in choroid area",
                                   "Change in choroid volume"
                            ],
                            "NCTId": [
                                   "NCT05016414"
                            ]
                     },
                     {
                            "Rank": 8,
                            "OverallOfficialName": [
                                   "Guy Trudel"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Recruiting"
                            ],
                            "OversightHasDMC": [],
                            "PatientRegistry": [
                                   "No"
                            ],
                            "Phase": [],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "November 30, 2022"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Anticipated"
                            ],
                            "PrimaryOutcomeDescription": [],
                            "PrimaryOutcomeMeasure": [
                                   "Hemolysis in astronauts is assessed using exhaled breath samples.",
                                   "Change from baseline hemolysis in astronauts is assessed during spaceflight using exhaled breath samples.",
                                   "Change from baseline hemolysis in astronauts is assessed after spaceflight, up to 1 month, using exhaled breath samples.",
                                   "Hemolysis in astronauts is assessed using blood markers CBC, reticulocytes, haptoglobin, bilirubin (total+direct), LDH, ferritin, iron, and TIBC.",
                                   "Change from baseline hemolysis in astronauts is assessed during spaceflight using blood markers CBC, reticulocytes, haptoglobin, bilirubin (total+direct), LDH, ferritin, iron, and TIBC.",
                                   "Change from baseline hemolysis in astronauts is assessed after spaceflight, up to 1 month, using blood markers CBC, reticulocytes, haptoglobin, bilirubin (total+direct), LDH, ferritin, iron, and TIBC."
                            ],
                            "NCTId": [
                                   "NCT05496309"
                            ]
                     },
                     {
                            "Rank": 9,
                            "OverallOfficialName": [
                                   "JOS\u00c9 VI\u00d1A, MD PhD (HON)"
                            ],
                            "OverallOfficialRole": [
                                   "Study Director"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [
                                   "Yes"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Phase 3"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "July 2016"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "Checks the loss of muscle mass percentage with Magnetic Resonance before and after treatment.",
                                   "Measure xanthine oxidase activity in plasma"
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Muscle mass loss",
                                   "The role of xanthine oxidase in the loss of muscle mass"
                            ],
                            "NCTId": [
                                   "NCT01987570"
                            ]
                     },
                     {
                            "Rank": 10,
                            "OverallOfficialName": [
                                   "Sara R Zwart, PhD"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Recruiting"
                            ],
                            "OversightHasDMC": [
                                   "No"
                            ],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Phase 1"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "July 1, 2027"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Anticipated"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "Measure change in total retinal thickness during and after flight compared to preflight using OCT"
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Optic Disc Edema"
                            ],
                            "NCTId": [
                                   "NCT05366933"
                            ]
                     },
                     {
                            "Rank": 11,
                            "OverallOfficialName": [
                                   "Arny Ferrando, PhD"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Not Applicable"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "June 2009"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [],
                            "PrimaryOutcomeMeasure": [
                                   "Fractional synthetic rate of muscle growth."
                            ],
                            "NCTId": [
                                   "NCT00447044"
                            ]
                     },
                     {
                            "Rank": 12,
                            "OverallOfficialName": [
                                   "Adam Gonzalez, PHD"
                            ],
                            "OverallOfficialRole": [
                                   "Principal Investigator"
                            ],
                            "OverallStatus": [
                                   "Completed"
                            ],
                            "OversightHasDMC": [],
                            "PatientRegistry": [],
                            "Phase": [
                                   "Not Applicable"
                            ],
                            "PointOfContactEMail": [],
                            "PointOfContactOrganization": [],
                            "PointOfContactPhone": [],
                            "PointOfContactPhoneExt": [],
                            "PointOfContactTitle": [],
                            "PrimaryCompletionDate": [
                                   "December 17, 2018"
                            ],
                            "PrimaryCompletionDateType": [
                                   "Actual"
                            ],
                            "PrimaryOutcomeDescription": [
                                   "Sheehan Disability Scale is a 3 item measure to assess functional impairment in work/school, social life, and family life.",
                                   "Depression Anxiety and Stress Scale is a 21-item measure to assess the severity of Depression, Stress, and Anxiety."
                            ],
                            "PrimaryOutcomeMeasure": [
                                   "Functional impairment in work/school, social life, and family life change",
                                   "Symptoms of Depression, Stress, and Anxiety Change"
                            ],
                            "NCTId": [
                                   "NCT05122429"
                            ]
                     }
              ]
       }
}